Location: Tokyo, Japan
CIK: 0002011385 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 12, 2024
Total Value: $125M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 8,644,579 | $105M | 83.5% | $7.85 | +54.2% | COM | 603170101 |
| PHAT | Phathom Pharmaceuticals, Inc. | 1,122,572 | $20.3M | 16.2% | $10.53 | +32.7% | COM | 71722W107 |
| — | HilleVax, Inc. | 236,379 | $416K | 0.3% | $16.05 | — | COM | 43157M102 |